drugset / Trial / NCT05691855
89Zr-labeled NY009 PET Imaging in Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY009 PET Imaging in patients
Timeline
- Start
- 2022-06-01
- Primary completion
- 2023-06
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 89Zr-NY009 | Diagnostic / imaging agent | 5 mg | — |
| Subject | 89Zr-NY009 | Diagnostic / imaging agent | 10 mg | — |
| Subject | 89Zr-NY009 | Diagnostic / imaging agent | 74 mbq | — |
| Subject | 89Zr-NY009 | Diagnostic / imaging agent | 111 mbq | — |